Top 20 biopharma companies Q3 2025 market cap up 4% despite headwinds
Their combined market capitalisation rose 4% from $3.7trn on 30 June 2025 to $3.8trn on 30 September 2025.
Biopharmaceutical Industry
Top 20 biopharma market caps fall 5.7% amid industry challenges
HHS launches $500m universal vaccines initiative
AstraZeneca CEO calls for increased European investment in pharma
Small biotechs shoulder the burdens of an uncertain biopharma sector
MSD’s Gardasil sales slide further due to China constraints
FDA layoffs and priority review programme’s lapse disrupt rare disease pipeline
J&J projects $400m tariff hit but raises sales outlook
